Kodiak Sciences Reports Positive Phase 3 Results for Zenkuda: Kodiak Sciences announced that Zenkuda and tabirafusp-ted achieved noninferiority to Regeneron's aflibercept in vision gains in the Phase 3 DAYBREAK study for wet age-related macular degeneration.… #MarketUpdates Follow Us for more
